Abiopharma

Talkspace Announces Second Quarter 2025 Results

Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2025 Financial Results

Allurion - Allurion Announces New Strategic Direction With Increasing Focus on Low-Dose GLP-1 Combination Therapy, Muscle Mass Maintenance, and US Market Entry

New Form 8-K - Talkspace, Inc. Filed: 2025-08-05 AccNo: 0000950170-25-102417 Size: 4 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Harmony Biosciences Holdings, Inc. Filed: 2025-08-05 AccNo: 0001558370-25-010182 Size: 3 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - NOVANTA INC Filed: 2025-08-05 AccNo: 0000950170-25-102416 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 8-K - Wave Life Sciences Ltd. Filed: 2025-08-05 AccNo: 0001193125-25-173053 Size: 15 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025

New Form 8-K - MESA LABORATORIES INC /CO/ Filed: 2025-08-05 AccNo: 0001437749-25-024714 Size: 316 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

NEXGEL Appoints Chief Accounting Officer of Shutterstock, Steve Ciardiello, CPA, to its Board of Directors

Lucid Diagnostics to Participate in Upcoming Investor Conferences

Xtant Medical to Announce Second Quarter 2025 Financial Results on August 12, 2025

Lucid Diagnostics to Participate in Upcoming Investor Conferences

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2025

Lineage Cell Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025